News
Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...
Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...
Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular ...
In a recent study published in Life Metabolism, researchers at Fudan University report that even after stopping the anti-obesity drug tirzepatide, ...
Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.
Learn how Mounjaro (tirzepatide) may reverse pre-diabetes in young adults in India, its benefits, and why early action is key.
Explore more
5h
News-Medical.Net on MSNCan one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonistsLandmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
12h
Flow Space on MSNIs This the Secret to Maintaining a Healthy Weight in Menopause?Menopause can feel like one big balancing act. Between managing your hormone levels and symptoms like hot flashes, night ...
A WOMAN has shared the brutally honest truth about what happened when she was forced to ”go cold turkey” from Mounjaro.
For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other ...
It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...
Explore how semaglutide and tirzepatide may protect against dementia and stroke—keep reading for clinical implications and evidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results